NBIX vs OBK · P/E 45, rev $1.77B vs P/E 18, rev $267.0M
Neurocrine Biosciences Inc (NBIX) versus Origin Bancorp, Inc. (OBK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Origin Bancorp, Inc. (OBK) is a banks - regional company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OBK revenue for 2026-06-30 was $267.0M. Net income was $61.5M. OBK currently screens at market cap $1.44B and trailing P/E 18.0.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OBK currently screens at market cap $1.44B and trailing P/E 18.0.
Not investment advice. Open the NBIX and OBK stock pages for the full models.
Not investment advice.